[1] 吴春晓,周晓蕾,陈燕鸿,等. 乙型肝炎相关性原发性肝癌发生的危险因素分析. 实用肝脏病杂志,2015,18(3):306-307. [2] 韩莹,丁惠国. 抗病毒治疗乙型肝炎肝硬化的过去、现在和将来. 实用肝脏病杂志,2015,18(5):453-456. [3] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2010年版).实用肝脏病杂志,2011,14(2):81-89. [4] 中华医学会传染病与寄生虫病学分会、肝病学分会. 病毒性肝炎防治方案. 中华肝脏病杂志,2000,8(6):324-329. [5] Lupsor M,Badea R,Stefanescu H,et a1.Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C. Results from a cohort of 324 patients.J Gastrointestin Liver Dis,2008,17(2):155-163. [6] Cadranel JF,Rufat P,Degos F. Practices of liver biopsy in France:results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology,2000,32(3):477-481. [7] 张舒眉,黄春旺,钟健,等. 超声造影对慢性乙型肝炎患者肝组织纤维化分级的诊断价值. 实用肝脏病杂志,2012,15(2):117-119. [8] 张琪,戴琳,陈永鹏,等. FibroScan弹性值测定在HBV感染所致肝衰竭患者中的应用价值. 中国康复,2009,24(2):120-122. [9] 张纯林,罗福成,童清平. 超声弹性成像在肝脏疾病中的应用.实用肝脏病杂志,2010,13(6):456-460. [10] Takemoto R,Nakamuta M,Aoyagi Y,et al.Validity of FibroScan values for predicting hepatic fibrosis stage in patients with chronic HCV infection.J Dig Dis,2009,10(2):145-148. [11] Ogawa E,Furusyo N,Toyoda K,et al.Transient elastography for patients with chronic hepatitis B and C virus infection:Non-invasive,quantitative assessment of liver fibrosis.Hepatol Res,2007,37(12):1002-1010. [12] 程小飞,梁雄波,熊晓红,等. 超声多普勒测定肝硬化患者门脉系统参数与Fibroscan得分的相关性分析. 实用肝脏病杂志,2013,16(2):111-112. [13] Sandrin L,Fourquet B,Hasquenoph JM,et a1. Transient elastography:a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol,2003,29(12):1705-1713. [14] Castera L,Vergniol J,Foucher J,et al.Prospective comparison of transient elastography,Fibrotest,APRI,and liver biopsy for the assessment of fibrosis in chronic hepatitis C.Gastroenterology,2005,128(2):343-350. [15] Fraquelli M,Rigamonti C,Casazza G,et al.Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut,2007, 56(7):968-973. [16] Stefanescu H,Griqorescu M,Lupsor M,et al. Spleen stiffness measurement using Fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients. J Gastroenterol Hepatol,2011,26 (1):164-170. [17] Millonig G,Reimann FM,Friedrich S,et al. Extrahepatic cholestasis increases liver stiffness(FibroScan) irrespective of fibrosis.Hepatology,2008,48(5):1718-1723. [18] Searle J,Mendelson R,Zelesco M,et a1. Non-invasive prediction of the degree of liver fibrosis in patients with hepatitis C using an ultrasound contrast agent.A pilot study.J Med Imaging Radiat Oncol,2008,52(2):1440-1673. [19] Tang A,Kim TK,Heathcote J,et a1. Does hepatic vein transit time performed with contrast-enhanced ultrasound predict the severity of hepatic fibrosis. Ultrasound Med Biol,2011,37(12):1963-1969. |